Advertisement

Tumor Biology

, Volume 37, Issue 4, pp 5089–5096 | Cite as

Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma

  • Zhiwu Ren
  • Shoulei Liang
  • Jilong Yang
  • Xiuxin Han
  • Luling Shan
  • Biying Wang
  • Tianyang Mu
  • Yanqin Zhang
  • Xueli Yang
  • Shunbin XiongEmail author
  • Guowen WangEmail author
Original Article

Abstract

Osteosarcoma is a highly aggressive bone disease with a tendency to metastasize to the lung. The 5-year survival of patients with metastatic osteosarcoma is only 20 %. Many studies have demonstrated SDF-1/CXCR4 and MMP9 play important roles in the metastasis of malignant tumors, including osteosarcoma. The aim of this study was to investigate the association of CXCR4 and MMP9 expression with clinicopathological features and pulmonary metastasis in osteosarcoma. Using tumor tissue microarrays, we analyzed the expression of CXCR4 and MMP9 among 34 primary osteosarcomas with pulmonary metastasis and 62 primary osteosarcomas without metastasis. A median time of 57.5 months (range: 6 to 171 months) follow-up was performed to evaluate tumor metastasis and the patient survival. The prognostic values were determined by univariate Kaplan-Meier survival analysis and multivariate Cox proportional hazard model analysis. The accuracy of oncologic outcome prediction was evaluated by receiver-operating characteristics (ROC) curves (AUC). The expression of CXCR4 and MMP9 was significantly correlated in tumor tissues (P = 0.026). Both CXCR4 and MMP9 were independent predictors for overall survival and metastasis-free survival by Cox multivariate analysis, and high expression for both CXCR4 and MMP9 were even more significant and better biomarkers for osteosarcoma metastasis and survival. The combination of CXCR4 and MMP9 high expression is very likely to be a valuable independent predictor of lung metastasis and survival in osteosarcoma patients.

Keywords

Osteosarcoma Chemokine (C-X-C-motif) receptor 4 (CXCR4) Matrix metalloproteinase 9 (MMP9) Pulmonary metastasis 

References

  1. 1.
    Ritter J, Bielack SS. Osteosarcoma. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2010;21 Suppl 7:vii320–5.Google Scholar
  2. 2.
    Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, et al. High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol. 2008;98:415–20.CrossRefPubMedGoogle Scholar
  3. 3.
    Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21:2011–8.CrossRefGoogle Scholar
  4. 4.
    Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4:540–50.CrossRefPubMedGoogle Scholar
  5. 5.
    Teicher BA, Fricker SP. Cxcl12 (sdf-1)/cxcr4 pathway in cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2010;16:2927–31.CrossRefGoogle Scholar
  6. 6.
    Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1/cxcr4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002;62:1832–7.PubMedGoogle Scholar
  8. 8.
    Yang YC, Lee ZY, Wu CC, Chen TC, Chang CL, Chen CP. Cxcr4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2007;17:676–86.CrossRefGoogle Scholar
  9. 9.
    Wagner PL, Hyjek E, Vazquez MF, Meherally D, Liu YF, Chadwick PA, et al. Cxcl12 and cxcr4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg. 2009;137:615–21.CrossRefPubMedGoogle Scholar
  10. 10.
    Perissinotto E, Cavalloni G, Leone F, Fonsato V, Mitola S, Grignani G, et al. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11:490–7.Google Scholar
  11. 11.
    Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161–74.CrossRefPubMedGoogle Scholar
  12. 12.
    Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol. 2012;181:1895–9.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Baldwin RM, Haghandish N, Daneshmand M, Amin S, Paris G, Falls TJ, et al. Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of mmp9 expression. Oncotarget. 2015;6:3013–32.CrossRefPubMedGoogle Scholar
  14. 14.
    Chen Y, Jiang T, Mao A, Xu J. Esophageal cancer stem cells express plgf to increase cancer invasion through mmp9 activation. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35:12749–55.CrossRefGoogle Scholar
  15. 15.
    Huang Q, Lan F, Wang X, Yu Y, Ouyang X, Zheng F, et al. Il-1beta-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of ap-1/c-fos, mmp2 and mmp9. Mol Cancer. 2014;13:18.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Wang X, Lu H, Urvalek AM, Li T, Yu L, Lamar J, et al. Klf8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of mmp9. Oncogene. 2011;30:1901–11.CrossRefPubMedGoogle Scholar
  17. 17.
    Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, et al. Cxcl12/cxcr4 signaling activates akt-1 and mmp-9 expression in prostate cancer cells: The role of bone microenvironment-associated cxcl12. Prostate. 2006;66:32–48.CrossRefPubMedGoogle Scholar
  18. 18.
    Nian WQ, Chen FL, Ao XJ, Chen ZT. Cxcr4 positive cells from lewis lung carcinoma cell line have cancer metastatic stem cell characteristics. Mol Cell Biochem. 2011;355:241–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Lee CC, Lai JH, Hueng DY, Ma HI, Chung Y, Sun YY, et al. Disrupting the cxcl12/cxcr4 axis disturbs the characteristics of glioblastoma stem-like cells of rat rg2 glioblastoma. Cancer Cell Int. 2013;13:85.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, et al. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional cxcr4. Cancer Res. 2004;64:8420–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Brand S, Dambacher J, Beigel F, Olszak T, Diebold J, Otte JM, et al. Cxcr4 and cxcl12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and mmp-9 activation. Exp Cell Res. 2005;310:117–30.CrossRefPubMedGoogle Scholar
  22. 22.
    Samara GJ, Lawrence DM, Chiarelli CJ, Valentino MD, Lyubsky S, Zucker S, et al. Cxcr4-mediated adhesion and mmp-9 secretion in head and neck squamous cell carcinoma. Cancer Lett. 2004;214:231–41.CrossRefPubMedGoogle Scholar
  23. 23.
    Murphy PM. Chemokines and the molecular basis of cancer metastasis. N Engl J Med. 2001;345:833–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Oda Y, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, Yokoyama R, et al. Cxcr4 and vegf expression in the primary site and the metastatic site of human osteosarcoma: Analysis within a group of patients, all of whom developed lung metastasis. Modern Pathol Off J US Can Acad Pathol Inc. 2006;19:738–45.Google Scholar
  25. 25.
    Laverdiere C, Hoang BH, Yang R, Sowers R, Qin J, Meyers PA, et al. Messenger rna expression levels of cxcr4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11:2561–7.CrossRefGoogle Scholar
  26. 26.
    Mira E, Lacalle RA, Buesa JM, de Buitrago GG, Jimenez-Baranda S, Gomez-Mouton C, et al. Secreted mmp9 promotes angiogenesis more efficiently than constitutive active mmp9 bound to the tumor cell surface. J Cell Sci. 2004;117:1847–57.CrossRefPubMedGoogle Scholar
  27. 27.
    Choi SH, Lee HJ, Jin YB, Jang J, Kang GY, Lee M, et al. Mmp9 processing of hspb1 regulates tumor progression. PLoS One. 2014;9:e85509.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, et al. Mmp9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell. 2002;2:289–300.CrossRefPubMedGoogle Scholar
  29. 29.
    van Kempen LC, Coussens LM. Mmp9 potentiates pulmonary metastasis formation. Cancer Cell. 2002;2:251–2.CrossRefPubMedGoogle Scholar
  30. 30.
    Liang S, Ren Z, Han X, Yang J, Shan L, Li L, et al. Pla2g16 expression in human osteosarcoma is associated with pulmonary metastasis and poor prognosis. PLoS One. 2015;10:e0127236.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, Sun M, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol Off J Am Soc Clin Oncol. 1993;11:449–53.CrossRefGoogle Scholar
  32. 32.
    Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Cancer. 2002;95:2202–10.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Zhiwu Ren
    • 1
  • Shoulei Liang
    • 1
  • Jilong Yang
    • 1
  • Xiuxin Han
    • 1
  • Luling Shan
    • 1
  • Biying Wang
    • 2
  • Tianyang Mu
    • 3
  • Yanqin Zhang
    • 3
  • Xueli Yang
    • 3
  • Shunbin Xiong
    • 4
    Email author
  • Guowen Wang
    • 1
    Email author
  1. 1.Department of Bone and Soft Tissue TumorTianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and TherapyTianjinChina
  2. 2.School of Ophthalmology & OptometryWenzhou Medical UniversityWenzhouChina
  3. 3.Institute of Cancer Stem CellDalian Medical University Cancer CenterDalianChina
  4. 4.Department of GeneticsThe University of Texas, M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations